
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 22, 2021, titled "Glenmark s Ryaltris��‐ innovative single nasal spray, ready to market in Russia".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 22, 2021, titled "Glenmark s Ryaltris��‐ innovative single nasal spray, ready to market in Russia".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals